FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

718928008: Albutrepenonacog alfa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3314442018 Albutrepenonacog alfa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3314443011 Albutrepenonacog alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
57031000195117 albutrepenonacog alfa it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
789511000172110 albutrepenonacog alpha fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
71171000195111 Albutrepenonacog alfa de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Albutrepenonacog alfa (substance) Is a Coagulation factor IX false Inferred relationship Some
Albutrepenonacog alfa (substance) Is a Fusion protein (substance) true Inferred relationship Some
Albutrepenonacog alfa (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Enzyme (disposition) true Inferred relationship Some
Albutrepenonacog alfa (substance) Is a Recombinant coagulation factor IX (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Albutrepenonacog alfa only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Albutrepenonacog alfa (substance) Inferred relationship Some 1
Product containing albutrepenonacog alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Albutrepenonacog alfa (substance) Inferred relationship Some 1
Albutrepenonacog alfa only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Albutrepenonacog alfa (substance) Inferred relationship Some 1
Albutrepenonacog alfa-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Albutrepenonacog alfa (substance) Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start